AstraZeneca and Oxford Say Vaccine Is Up to 90 Percent Effective

In an early analysis, the drug maker zeroed in on a promising dosing plan for its vaccine.In an early analysis, the drug maker zeroed in on a promising dosing plan for its vaccine.Clinical Trials, Coronavirus (2019-nCoV), Vaccination and Immunization, Drugs (Pharmaceuticals), AstraZeneca PLC, Oxford University, Coronavirus Risks and Safety ConcernsRead More